<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Shenzhen_SFLS_Drug_Designing skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Shenzhen SFLS/Drug Designing</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Team:Shenzhen SFLS/Demonstrate - 2017.igem.org</TITLE></P><DIV id="header"><NAV class="sfls-nav" role="navigation"><DIV class="container"><DIV class="row"><DIV class=" text-center menu-1 "><UL><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS">Project</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Description ">Description</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Design ">Design</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Experiments ">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate ">Demonstrate</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Collaborations ">Collaboration</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Achievement ">Achievement</A></LI></UL><LI class="has-dropdown"><A href="#">Parts</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Basic_Part ">basic part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Composite_Part ">composite part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Model">Modeling</A></LI><LI class="has-dropdown"><A href="#">Human Practice</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated ">GOLD</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver ">SILVER</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Publicity ">Publicity</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Biosafety ">Biosafety</A></LI><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Protocols ">protocols</A></LI><LI class="has-dropdown"><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team">Team</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team">About us</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Attributions ">Attributions</A></LI></DIV></DIV></DIV></NAV></DIV><TITLE>Team:Shenzhen SFLS/Demonstrate - 2017.igem.org</TITLE><DIV class="img_head_bar text-center"><DIV class="display-t" style="background-image:url(https://static.igem.org/mediawiki/2017/c/c4/Sfls-title-modeling.svg); background-repeat:no-repeat; background-attachment:fixed"><DIV class="display-tc"><H1>Drug Designing</H1></DIV></DIV></DIV><DIV class="marin_top"><DIV class="marin_top_content"><DIV id="tbox"><A class="taoba" href="#index_4" title="4">Introduction</A><A class="taoba" href="#index_1" title="1">Diffusion part</A><A class="taoba" href="#index_5" title="5">Reaction part</A><A class="taoba" href="#index_2" title="2">Future work</A><A class="taoba" href="#index_3" title="3">Reference</A><A id="gotop" href="javascript:void(0)" title="回到顶部">回到顶部</A></DIV><DIV class="main_context" id="main"><DIV class="row"><DIV class="mainpage mainpage4"><H5 id="index_4">Introduction</H5><P>At first, we intended to use liposome as genetic vector. However, experiment data shows that liposome (has blank plasmid in it) has a high cytotoxic effect. When the liposome concentration is 4μg/mL, the number of cells died from cytotoxic
              effect is even greater than the number of survival cells (G361). Because the malignant degree of A375 is higher than G361, cytotoxic effect seems much weaker in A375.</P><P>Therefore, we planned to use lentivirus as gene vector, which is reported to have lower cytotoxic effect and higher transduction efficiency than liposome vector. Lentiviruses enter into cells when transducing, while most kinds of viruses bind
              to cellular membrane and inject their genetic material into cells.</P><P>As the picture shown, the lentiviruses behave two ways in vivo: Diffusion and reaction (entering cells). The concentration of drug is a function of time (since injection of drug) and position (the distance to drug injection site).</P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage1"><H5 id="index_1">Diffusion part</H5><P>we assume that lentiviruses diffusing in extracellular substance is unsteady-state diffusion, which follows Fick’s Second Law:</P><P>C<SUB>diff</SUB> is the concentration of drug which participates diffusion ,C is the concentration of drug at certain time and position.  t is time,  D is the diffusion coefficient,
   ∇C is the concentration gradient of drug in vivo.
</P><P>In order to reduce the quantity of calculation, we consider the diffusion coefficient  D is a constant, which does not change over time or space. Thus, the equation can be written as:</P><P>Δ is the Laplace operator.</P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage5"><H5 id="index_5">Reaction part</H5><P>We assume that at each moment, the number of lentiviruses entering into cells is proportional to the concentration of lentivirus at which time and position.</P><P>C<SUB>reac</SUB> is the concentration of drug which participates the reaction,C is the concentration of drug at certain time and position, k is a constant.</P><P>Combining the two terms together, we have:</P><P>The partial differential equation has the following boundary conditions:</P><P>I means that at the moment of injection, the drug has not diffused or entered into cells, so the concentration at the injection site is the initial drug concentration C<SUP>0</SUP>.</P><P>II means that when drug gets to the border of the dermis and subcutaneous tissue (where the distance to injection site is χ<SUB>c</SUB>), it will be immediately taken away through the complex network of blood vessels.</P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage2"><H5 id="index_2">Future work</H5><P>Due to the limited time, we could not realize our genetic circuit into drugs. We also failed to find data from the existing articles with which the values of parameters can be perfectly determined.</P><P>After determining the parameters, we can know the concentration at any time and position, when the initial concentration is set.</P></DIV></DIV><DIV class="row"><DIV class="mainpage mainpage3" id="“reference”"><H5 id="index_3">Reference</H5></DIV></DIV></DIV><DIV class="img_bottom_bar  text-center"><DIV class="display-t"><DIV class="display-tc"><H1> </H1></DIV></DIV></DIV><FOOTER id="sfls-footer" role="contentinfo"><DIV class="container"><DIV class="row row-pb-md"><DIV class="col-md-4 sfls-widget"><H3><A href="home.html">SFLS.</A></H3><P id="ours">Shenzhen Foreign Language School, Yantian Road No.1, Yantian District, Shenzhen, Guangdong, China</P></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS">Home</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Description ">Description</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Design ">Design</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Experiments ">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Demonstrate ">Demonstrate</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Collaborations">Collaboration</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Achievement">Achievement</A></LI></UL></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Basic_Part ">Basic Part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Composite_Part ">Composite Part</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Model ">Modeling</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Silver ">HP-Silver</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/HP/Gold_Integrated ">HP-Gold</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Biosafety ">Biosafety</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Protocols">Protocols</A></LI></UL></DIV><DIV class="col-md-2 col-sm-4 col-xs-6 col-md-push-1"><UL class="sfls-footer-links"><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Team ">About us</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Attributions ">Attribution</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Engagement">Engagement</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Contribution">Contribution</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Notebook ">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Publicity ">Publicity</A></LI><LI><A href="https://2017.igem.org/Team:Shenzhen_SFLS/Improve">Improve</A></LI></UL></DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>